Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Pfa100 Colepi And Coladp

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT03621020Completed

Clinical Performance Evaluation of T-TAS 01 PL Chip

Showing all 1 trials

Research Network

Common Treatments

  • Pfa100 Colepi And Coladp1
  • Ttas 01 Pl Chip1

Active Sponsors

  • Fujimori Kogyo Co., Ltd.1
  • Hikari Dx, Inc.1

Top Investigators

Related Conditions

  • Platelet Dysfunction1
  • Von Willebrand Diseases1
  • Healthy1

Activity Timeline